Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anticancer therapy and lung injury: molecular mechanisms.
Li L, Mok H, Jhaveri P, Bonnen MD, Sikora AG, Eissa NT, Komaki RU, Ghebre YT. Li L, et al. Among authors: mok h. Expert Rev Anticancer Ther. 2018 Oct;18(10):1041-1057. doi: 10.1080/14737140.2018.1500180. Epub 2018 Jul 23. Expert Rev Anticancer Ther. 2018. PMID: 29996062 Free PMC article. Review.
Computer-aided segmentation on MRI for prostate radiotherapy, Part I: Quantifying human interobserver variability of the prostate and organs at risk and its impact on radiation dosimetry.
Sanders JW, Mok H, Hanania AN, Venkatesan AM, Tang C, Bruno TL, Thames HD, Kudchadker RJ, Frank SJ. Sanders JW, et al. Among authors: mok h. Radiother Oncol. 2022 Apr;169:124-131. doi: 10.1016/j.radonc.2021.12.011. Epub 2021 Dec 16. Radiother Oncol. 2022. PMID: 34921895
Computer-aided segmentation on MRI for prostate radiotherapy, part II: Comparing human and computer observer populations and the influence of annotator variability on algorithm variability.
Sanders JW, Mok H, Hanania AN, Venkatesan AM, Tang C, Bruno TL, Thames HD, Kudchadker RJ, Frank SJ. Sanders JW, et al. Among authors: mok h. Radiother Oncol. 2022 Apr;169:132-139. doi: 10.1016/j.radonc.2021.12.033. Epub 2021 Dec 31. Radiother Oncol. 2022. PMID: 34979213
Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study.
Tang C, Sanders J, Thames H, Swanson DM, Crook JM, Bruno T, Blanchard P, Ciezki J, Keyes M, Song D, Singh T, Merrick G, Stock R, Sullivan FJ, Mok H, Millar J, Frank SJ. Tang C, et al. Among authors: mok h. Radiother Oncol. 2023 Jun;183:109599. doi: 10.1016/j.radonc.2023.109599. Epub 2023 Mar 7. Radiother Oncol. 2023. PMID: 36889593
355 results